Fremanezumab shown to be effective in treating acute and episodic migraine, according to a new presentation at PAINWeek 2018.
Headache and Migraine
Vestibular migraine may be a relatively new diagnostic entity, but a new study shows it impacts around 6 million US adults.
Primary care clinicians may be the first to note an abnormal headache pattern that calls for referral. What do you know about these not-so-simple headaches?
Noninvasive vagus nerve stimulation may be a viable method for the treatment of acute episodic migraine, according to a new study.
The first CGRP mAb has been FDA-approved, but why should you consider this novel category for migraine prevention?
Menstrual migraine can be a tricky diagnosis. Test your knowledge of the headaches and gather clinical tips with our 8-question quiz.
Take a closer look at how erenumab, the first CGRP inhibitor to win FDA-approval for migraine prevention, earned that spot.
How much do you know about migraine/severe headache in the US? Take our 10-question quiz to find out.
Results from a recent analysis of trends in US migraine prevalence show disease burden higher in populations that may be neglected. Are any of your patients at risk?
Drugs that treat migraine come from a variety of classes and reflect on- and off-label use. How current are you?